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Availability of genomic sequence data provides opportunities to study the role of low-frequency and rare variants
in the etiology of complex disease. In this study, we conduct association analyses of hypertension status in the cohort
of 1943 unrelated Mexican Americans provided by Genetic Analysis Workshop 19, focusing on exonic variants in MAP4
on chromosome 3. Our primary interest is to compare the performance of standard and sparse-data approaches
for single-variant tests and variant-collapsing tests for sets of rare and low-frequency variants. We analyze both
the real and the simulated phenotypes.Background
Despite the success of genome-wide association studies,
much of the genetic contribution to complex diseases
and traits remains unexplained. Therefore, an increasing
number of studies have turned to low-frequency and
rare variant association analysis for additional explan-
ation of disease risk or trait variability. For binary phe-
notypes, single-variant analyses of low-frequency and
rare variants are challenging because the conventional
logistic regression approaches often violate the large-
sample-size assumption for test statistics, resulting in
poor type 1 error control or low statistical power [1, 2].
The standard score test, in particular, can be extremely
anticonservative under the null [3]. Variant-collapsing
methods across multiple variants or sparse-data methods
for single-variant analysis offer an alternative [1–5]. Fur-
thermore, depending on the linkage disequilibrium (LD)
structure, it is possible that even nonfunctional low-
frequency or common variants can capture functional
rare variant signals [4]. On the other hand, because
power is higher for a variant with a higher minor allele
frequency (MAF), a common functional variant will* Correspondence: shin@lunenfeld.ca; bull@lunenfeld.ca
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(http://creativecommons.org/publicdomain/zeusually be better detected by a single-variant test rather
than as part of a collapsing test that incorporates non-
functional variants.
In this report, we analyze the exome-sequence data
and both the real and simulated phenotype data of the
unrelated Mexican American sample to evaluate and
compare the performance of single-variant and variant-
collapsing methods for association analysis.
Methods
To relate genotypes to hypertension, we consider the
logistic regression model
logit P HTNi ¼ 1 jcovariatesð Þð Þ
¼ β0 þ AGEiβa þ SEXiβs þ Giβg ;
where i = 1, …, 1943 indexes the individuals, HTNi indi-
cates hypertension status of the ith individual (1 if the
individual is hypertensive and 0, otherwise); AGEi is the
age at the time of examination, SEXi is the gender of the
individual, and Gi ¼ Gi1 ;Gi2 ; …; Gimð Þ indicates the
vector containing the numbers of copies of the nonrefer-
ence alleles at m variants (ie, additively coded genotype),
and βg
0 ¼ β1; β2;…; βm
 
is the vector of the associated
parameters.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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types of nonstandard approaches: Firth-type penalized
logistic regression likelihood ratio (LR) tests [2, 6–8],
and small-sample adjusted score tests [9], and compare
them to standard LR and score tests. The LR and score
tests are asymptotically equivalent but may be discrepant
in finite samples. The penalized LR test is based on the
penalized log-likelihood function
lp βð Þ ¼ l βð Þ þ 12 log i βð Þj jð Þ;
where i(β) is the Fisher information matrix. This is a
generalization of Haldane’s statistic for sparse 2 × 2 table
analysis, where 12 is added to each cell. For the small-
sample-adjusted single-variant score tests, we apply an
approach to adjust the null distribution of the test statistic
by incorporating small-sample variance and/or kurtosis
(see Lee et al. [9], pp. 226–227); this approach was origin-
ally recommended for variant-collapsing tests.
For variant-collapsing analysis, we consider a MAF-based
weighted burden test [1], a nonburden sequence kernel as-
sociation test (SKAT) and a unified approach (SKAT-O)
that optimally combines a burden test and a SKAT (eg, Lee
et al. [9]). For these tests, we first define K subregions, then
pool the variants within each subregion, and test K null
hypotheses H0K : β1; β2;…; βmk
 0
¼ 0; 0;…; 0ð Þ0 , where
mk indicates the number of variants within the k-th
subregion (k = 1,…, K). For convenience, we determine
the subregions on the basis of physical proximities
among the variants.a
Fig. 1 Pairwise LD measures for markers within MAP4 region on chromos
used for annotation. In panel (a), each pixel represents pairwise LD, meas
markers. In panel (b), LD is measured by Lewontin’s |D'|. The latter are general
constrained by the allele frequencies. As indicated by the color key, stro
was produced using the LDheatmap package [16]Applying these methods, we analyzed exonic variants
within MAP4 gene on chromosome 3 in the real and
the simulated phenotype data sets. For the imputed var-
iants, we analyzed the predicted dosages rather than
their best-guess genotypes. In addition, we examined all
polymorphic variants, including the singletons to assess
the extremes at which the tests break down. For the
standard and penalized logistic regression tests, we
used the R glm function and pmlr (Penalized Multi-
nomial Logistic Regression) package [10], respectively.
For the small-sample-adjusted score test and the
variant-collapsing tests, we used the R package SKAT
[11], with analytical variance estimates and empirical
kurtosis estimates based on 10,000 bootstrap replicates.
For the variant-collapsing methods, we let K = 6 based
on a visual inspection of the physical positions of the
variants (Fig. 1a).
Data preparation
In the real data set, we defined the hypertension pheno-
type using the conventional diagnostic criteria: a systolic
blood pressure (SBP) greater than 140 mm Hg or a
diastolic blood pressure (DBP) greater than 90 mm
Hg. We also defined individuals on antihypertensive
medication to be hypertensive regardless of their SBP
and DBP levels.
For the simulated phenotypes, 2 data sets were avail-
able, “SIMQ1” and “SIMPHEN,” each with 200 repli-
cates. SIMQ1, designed for evaluating type 1 error rates,
contained normally distributed Q1 generated under no
genetic effects. Because SIMQ1 did not have binary phe-
notypes, we dichotomized Q1 to create hypotheticalb
ome 3 in 1943 unrelated samples. The hg19 genome assembly was
ured by the squared allelic correlation coefficient r2 between 2
ly higher because |D'| takes into account that the correlation is
nger LD is represented by red and weaker by white. The LD plot
Table 1 Frequencies of rare (MAF <1 %), low-frequency (1 % ≤
MAF <5 %) and common (MAF ≥5 %) variants in K = 6 subregions
within MAP4 region on chromosome 3
Subregion Variant IDs Rarea Low-frequencya Commona Totala
1 1–16 14 (4) – 2 (0) 16 (4)
2 17–38 20 (7) 2 (0) – 22 (7)
3 39–53 15 (0) – – 15 (0)
4 54–77 20 (10) 2 (1) 2 (2) 24 (13)
5 78–86 9 (0) – – 9 (0)
6 87–90 3 (1) 1 (1) – 4 (2)
Total – 81 (22) 5 (2) 4 (2) 90 (26)
aThe values in parentheses indicate the numbers of variants designated as
functional in the simulation study
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through Q1. We let Q2 = 1 if Q1 was greater than 51.2 and
0 otherwise, such that the disease prevalence for Q2 was
17.8 %, the same as the prevalence of hypertension in
SIMPHEN, which we used for evaluating power. The
hypertension phenotype was derived from blood pressure
phenotypes generated under a model with more than
1000 variants in more than 200 genes [12].
Results
MAP4 variants in the unrelated sample
Of the 409 exonic MAP4 variants, only 90 were poly-
morphic in the sample of 1943 unrelated individuals.
These variants had MAFs ranging from 0.00027 to
0.34. As expected, rare variants (MAF <1 %) were
most prevalent in the sample; except for 4 common
variants, all variants had MAF less than 5 % (Fig. 2,
Table 1). As expected for rare variants (eg, Pritchard
[13]), the pairwise LD in the 90 variants was generally
weak, with the exception of a few variants in strong
LD in an upstream region (see Fig. 1). However, the
strong LD seems to arise because of their physical
proximities (all the markers in the LD block are located
within 39 bases).Fig. 2 Distribution of the frequency for the 90 polymorphic MAP4 variants
Height of the bars indicates the total number of variants for a given count
functional variants used in the simulation modelAnalysis of the real phenotype data
We found that the standard score test rejects the null
hypothesis far more often than the other single-variant
tests (results not shown), suggesting that it may be anti-
conservative. This agrees with published simulations
under a case-control design [3] and is confirmed by our
own unpublished simulation studies under a cohort
design at the observed hypertension prevalence ofaccording to the number of individuals with genotype dosage G > 0.
of observations with G > 0, and red bars indicate the counts for the 26
The Author(s) BMC Proceedings 2016, 10(Suppl 7):39 Page 392 of 41526 %. After correcting for multiple testing, no single-
variant tests identified any association (minimum un-
adjusted p value = 0.006). The burden, SKAT and
SKAT-O (optimal sequence kernel association test)
tests, each of which pooled all polymorphic variants
within the K = 6 subregions defined in Table 1 and
Fig. 1a, did not find the MAP4 gene to be significant
either (minimum unadjusted p values = 0.12, 0.24, and
0.20, respectively).
Analysis of the simulated phenotype data
It has been demonstrated that for a genome-wide study
with a large sample size, minor allele count (MAC) is
the key parameter determining test calibration [3]. Be-
cause we analyzed predicted dosages, we do not have a
MAC for all the variants. Hence, for the presentation of
simulation results, we use the count of individuals with
G > 0 dosage, denoted by gMAC , which is close to the
MAC for a low MAF. For type 1 error rates of the
single-variant tests, we pooled the results across all vari-
ants with the same values of gMAC. Power for the single-
variant tests was evaluated separately for each of the 26
functional variants. For the variant-collapsing tests,
power was examined for each subregion containing at
least one functional variant.
Test size and type I error
Examination of quantile–quantile (Q-Q) plots of the single-
variant test p values for rare variants revealed departures
from the expected distribution under the null hypothesis of
no genetic effects with some discrepancies among tests. Fora b
Fig. 3 Q-Q plots of p values from the single-variant tests under the null hypo
likelihood ratio test (PLRT), standard score test (Score) and small-sample-adjus
yellow squares, black circles, red point-down triangles, purple diamonds,
a rare, a low-frequency, and a common variant with gMAC = 1, 87, and 1065 o
replicates of the null binary phenotypes Q2example, for var_3_47660325, with gMAC ¼ 1; all the
single-variant tests showed unusual departures from the
expected (Fig. 3a). For low-frequency variants, the p value
distributions were close to the expected, except in the
upper tail where all tests seemed to be anticonservative (eg,
Fig. 3b). As expected, the common variant test p values
were close to the null distribution with no discrepancy
among the tests (eg, Fig. 3c).
Examination of empirical type 1 error rates for the
single-variant tests demonstrates that no method per-
formed uniformly better than others for the rare variants
with very low MACs (Fig. 4). For example, when gMAC
is less than 15, the standard score test tended to be
anticonservative at a significance testing level of 0.01
(Fig. 4), but was conservative at the less stringent signifi-
cance level of 0.05 (results not shown). The standard LR
test tended to be conservative for low gMAC (eg, <10),
but could be anticonservative when this count was be-
tween 10 and 20. Although the 2 small-sample score
tests could also be anticonservative, and the penalized
LR test tended to be conservative in general, the type 1
error rates of these tests were closer to the nominal level
than the standard tests. When gMAC is 66 or greater (or
MAF >1 %), all the single-variant tests seem to control
type 1 error reasonably well.
Power
All the single-variant tests had power of less than 20 %
to detect each of the rare variants, but had 100 % power
for the low-frequency and the common variants at the
significance levels of 0.01 and 0.05. For the low-c
thesis. The p values from the standard likelihood ratio test (LRT), penalized
ted score tests (Score-Var-Adj and Score-Var-Kurt-Adj) are indicated by
and green point-up triangles, respectively. Panels (a), (b), and (c) show
bservations with genotype dosage G > 0. The results are based on 200
Fig. 4 Empirical type 1 error rates of the single-variant tests at significance level of 0.01, according to the number gMAC of observations
with genotype dosage G > 0 in the 1862 individuals with complete information on AGE and SEX. For the count-specific assessment, the
results were pooled for the variants with the same gMAC value, and the proportions of the p values <0.01 were then computed. Tests are
the standard likelihood ratio test (LRT), penalized likelihood ratio test (PLRT), standard score test (Score) and small-sample-adjusted score
tests (Score-Var-Adj and Score-Var-Kurt-Adj), which are indicated by yellow squares, black circles, red point-down triangles, purple diamonds,
and green point-up triangles, respectively. The vertical line segments indicate ±2 simulation error bars, which were calculated based on the total
number of the polymorphic variants in each gMAC -specific group. For example, for the variants with gMAC = 1, the error bars were obtained
based on 200 × 44 = 8800 simulated data sets
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differential power at a stricter significance level. For ex-
ample, in Fig. 5b, all the tests for var_3_47957996 (MAF
= 0.0024) had p values of less than 0.01; however, the 2
LR tests had consistently lower p values than the 3 score
tests. At a significance level of 1e–06, the standard and
penalized LR tests had 91 and 82 % power, respectively,
whereas the standard, the small-sample-variance, and
the small-sample-variance-kurtosis score tests had less
than 10 % power.
Among the 4 subregions with at least 1 functional
variant, power was nonnegligible only in subregions 4
and 6 (Table 2). Figure 5d-f shows the results from the
variant-collapsing tests of the markers in subregion 4,
which contains all 3 types of functional variants (rare,
low-frequency, and common). As expected, the burden
test tended to have lower power than SKAT or SKAT-
O because the subregion includes both protective and
deleterious variants. These tests all had low power
when the subregion includes only rare variants (eg,
Fig. 5d). The power improved when the subregion in-
cluded both the rare and the low-frequency functional
variants (eg, Fig. 5e). When, however, the common vari-
ants were additionally included, the power did not seem
to improve further (Fig. 5f ). When compared with the
single-variant tests of markers in the same subregion
(Fig. 5b and c), the results suggest that this subregion
would have been detected by some of the single-variant
tests, as well, even at the genome-wide significance
level of 5e–08.Discussion and conclusions
In this article, we evaluated standard and sparse-data
methods for single-variant and variant-collapsing tests to
examine the association between a hypertension pheno-
type and exonic variants in MAP4 gene on chromosome
3, using both the real and the simulated phenotypes in
unrelated Mexican Americans.
In the analysis of the real phenotype data, none of
the single-variant and the variant-collapsing methods
detected MAP4 variants significantly associated with
hypertension. A limitation of our analysis is that we
did not make any adjustment for ancestry admixture/
population structure. In genetic association studies of
admixed populations such as Mexican Americans, ad-
dressing differential ancestral backgrounds is import-
ant to avoid false positive or negative association
signals [14, 15].
In our simulation investigation, we found that the
sparse-data approaches improve type 1 error control,
but their power remains low for detecting the rare vari-
ant effects. Because power of the association tests de-
pends on both frequency and effect size of rare variants,
even with large effects, the tests may detect rare variants
only in studies with large samples. We may be more suc-
cessful in identifying rare variants when we use joint or
meta-analyses combining data or summary statistics
from different studies (eg, Ma et al. [3]). For the low-
frequency variants, all the single-variant tests seem to
have improved type 1 error rates and power. It seems






Fig. 5 Q-Q plots of the p values from the single-variant tests and variant-collapsing tests of markers in subregion 4 (see Table 1 and Fig. 2a).
Panels (a) to (c) show the p values from the single-variant tests for a rare, low-frequency, and common functional variant, respectively; the tests
are the standard likelihood ratio test (LRT), penalized likelihood ratio test (PLRT), standard score test (Score) and small-sample-adjusted score tests
(Score-Var-Adj and Score-Var-Kurt-Adj), which are indicated by yellow squares, black circles, red point-down triangles, purple diamonds, and green
point-up triangles, respectively. Panels (d) to (f) show the results from the variant-collapsing tests when they include the rare variants, rare and
low-frequency variants, and all the variants within the region. The p values from the weighted burden tests, SKAT, and SKAT-O are, respectively,
represented by pink circles, blue cross marks, and green diamonds. The calculations are based on 200 simulated data sets in SIMPHEN
Table 2 Empirical power estimates of the collapsing-variant tests based on 200 simulated data sets in SIMPHEN, according to the
MAP4 subregions containing at least 1 functional variant
Burdena SKATa SKAT-Oa
Significance level Subregion Rare Rare & low- frequency All Rare Rare & low- frequency All Rare Rare & low- frequency All
0.01 1 0 0 0.260b 0.005 0.005 0.840b 0.005 0.005 0.805b
2 0 0.005 0.005 0 0.145 0.145 0 0.090 0.080
4 0 0.955 0.955 0 1.000 1.000 0 1.000 1.000
6 0 0.990 0.995 0 1.000 1.000 0 1.000 1.000
0.05 1 0.045 0.045 0.555b 0.015 0.020 0.960b 0.015 0.015 0.970b
2 0.060 0.030 0.030 0.020 0.330 0.330 0.005 0.255 0.250
4 0.030 0.990 0.990 0.025 1.000 1.000 0.015 1.000 1.000
6 0.105 1.000 1.000 0.075 1.000 1.000 0.085 1.000 1.000
aFor each subregion, power was estimated when a test includes only rare, rare and low-frequency, and all variants
bA result of 2 nonfunctional common variants that were in LD (r2 > 0.3) with the 2 functional common variants in subregion 4
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make any concrete conclusions because of the limited
number of replications provided in the simulation de-
sign. Although more thorough investigation is necessary,
overall, the penalized LR test and the score test with
small-sample variance and kurtosis seem to be better
choices than the standard tests for the analyses of rare
and low-frequency variants. Moreover, caution is indi-
cated when different tests of the same hypothesis give
inconsistent p values as it suggests large-sample approxi-
mations for test statistics may be invalid.
Although previous simulation studies have shown that
collapsing tests can have greater power than single-
variant tests (see, eg, Madsen and Browning [1]), our
investigation suggests that power of collapsing tests can
be low when the tests include only the rare variants
(see, eg, Fig. 5d). In addition to MAF and effect size,
power of collapsing tests depends on the number of as-
sociated variants, the number of neutral variants, and
whether the direction of effects is consistent within
gene, so that selection of good binning and weighting
strategies may boost power for detecting regions con-
taining only rare variants.
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